122 related articles for article (PubMed ID: 30907230)
1. Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis.
Knott RJ; Harris A; Higgins A; Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars MB; Vallance S; Varma D; Wills J; Bellomo R
J Neurotrauma; 2019 Sep; 36(17):2541-2548. PubMed ID: 30907230
[TBL] [Abstract][Full Text] [Related]
2. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
Trials; 2014 Dec; 15():501. PubMed ID: 25528574
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial.
Skrifvars MB; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
J Trauma Acute Care Surg; 2017 Sep; 83(3):449-456. PubMed ID: 28590358
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of erythropoietin in patients with traumatic brain injury: a meta-analysis of randomized controlled trials.
Liu WC; Wen L; Xie T; Wang H; Gong JB; Yang XF
J Neurosurg; 2017 Jul; 127(1):8-15. PubMed ID: 27367243
[TBL] [Abstract][Full Text] [Related]
6. The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
Skrifvars MB; Luethi N; Bailey M; French C; Nichol A; Trapani T; McArthur C; Arabi YM; Bendel S; Cooper DJ; Bellomo R;
Intensive Care Med; 2023 Jul; 49(7):831-839. PubMed ID: 37405413
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
[TBL] [Abstract][Full Text] [Related]
8. Cause and Timing of Death and Subgroup Differential Effects of Erythropoietin in the EPO-TBI Study.
Skrifvars MB; French C; Bailey M; Presneill J; Nichol A; Little L; Durantea J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R
J Neurotrauma; 2018 Jan; 35(2):333-340. PubMed ID: 29020866
[TBL] [Abstract][Full Text] [Related]
9. Potential Efficacy of Erythropoietin on Reducing the Risk of Mortality in Patients with Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
Liu C; Huang C; Xie J; Li H; Hong M; Chen X; Wang J; Wang J; Li Z; Wang J; Wang W
Biomed Res Int; 2020; 2020():7563868. PubMed ID: 33178833
[TBL] [Abstract][Full Text] [Related]
10. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial.
Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC
J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin to Reduce Mortality in Traumatic Brain Injury: A Post-hoc Dose-effect Analysis.
Gantner DC; Bailey M; Presneill J; French CJ; Nichol A; Little L; Bellomo R; ;
Ann Surg; 2018 Mar; 267(3):585-589. PubMed ID: 28151802
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of erythropoietin for traumatic brain injury.
Liu M; Wang AJ; Chen Y; Zhao G; Jiang Z; Wang X; Shi D; Zhang T; Sun B; He H; Williams Z; Hu K
BMC Neurol; 2020 Nov; 20(1):399. PubMed ID: 33138778
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of erythropoietin in treating experimental traumatic brain injury: a systematic review of controlled trials in animal models.
Peng W; Xing Z; Yang J; Wang Y; Wang W; Huang W
J Neurosurg; 2014 Sep; 121(3):653-64. PubMed ID: 25036201
[TBL] [Abstract][Full Text] [Related]
14. Meta-Analysis with Trial Sequential Analysis on the Efficacy and Safety of Erythropoietin in Traumatic Brain Injury: A New Paradigm.
Katiyar V; Chaturvedi A; Sharma R; Gurjar HK; Goda R; Singla R; Ganeshkumar A
World Neurosurg; 2020 Oct; 142():465-475. PubMed ID: 32450313
[TBL] [Abstract][Full Text] [Related]
15. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
[TBL] [Abstract][Full Text] [Related]
16. Time to reconsider extended erythropoietin treatment for infantile traumatic brain injury?
Jantzie L; El Demerdash N; Newville JC; Robinson S
Exp Neurol; 2019 Aug; 318():205-215. PubMed ID: 31082389
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit.
Zhang Y; Xiong Y; Mahmood A; Meng Y; Qu C; Schallert T; Chopp M
Brain Res; 2009 Oct; 1294():153-64. PubMed ID: 19646970
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury: A randomized, double blind and controlled clinical trial.
Li ZM; Xiao YL; Zhu JX; Geng FY; Guo CJ; Chong ZL; Wang LX
Clin Neurol Neurosurg; 2016 Nov; 150():80-83. PubMed ID: 27611985
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of combined cognitive and vocational rehabilitation in patients with mild-to-moderate TBI: results from a randomized controlled trial.
Howe EI; Andelic N; Fure SCR; Røe C; Søberg HL; Hellstrøm T; Spjelkavik Ø; Enehaug H; Lu J; Ugelstad H; Løvstad M; Aas E
BMC Health Serv Res; 2022 Feb; 22(1):185. PubMed ID: 35151285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
